Augmentation of antitumour activity of defucosylated chimeric anti-CCR4 monoclonal antibody in SCID mouse model of adult T-cell leukaemia/lymphoma using G-CSF.

Br J Haematol · 2008 · PMC2268953 · PMID 18205860

Europe PMC DOI

hedged sentence

0.0053

closest p · 0.1× alpha

0.0053

boldest claim

The sentences

highly significantP = 0·0053actually significant

The difference between the tumour volume in animals treated with KM2760 plus G-CSF and those with KM2760 alone was highly significant ( P = 0·0053) ( Fig 1B and C ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.